Demonstration of loss of attenuation and extended field persistence of a live avian metapneumovirus vaccine

Vaccine

Volumn 24, Issue 42-43, 2006, Pages 6476-6482

  Catelli, Elena ^a   Cecchinato, Mattia ^a   Savage, Carol E ^b   Jones, Richard C ^b   Naylor, Clive J ^b  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b UNIVERSITY OF LIVERPOOL   (United Kingdom)

Author keywords

Metapneumovirus; Vaccine; Virulence

Indexed keywords

AVIAN METAPNEUMOVIRUS VACCINE; LIVE VACCINE; UNCLASSIFIED DRUG;

AMINO ACID SUBSTITUTION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; NONHUMAN; NUCLEOTIDE SEQUENCE; PERSISTENT VIRUS INFECTION; POULTRY; PRIORITY JOURNAL; TURKEY (BIRD); VIRULENCE; VIRUS ATTENUATION; VIRUS ISOLATION;

ANIMALS; DISEASE OUTBREAKS; METAPNEUMOVIRUS; PARAMYXOVIRIDAE INFECTIONS; POULTRY DISEASES; RESPIRATORY MUCOSA; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, VIRAL; TURKEYS; VACCINES, ATTENUATED; VIRAL VACCINES;

EID: 33749591543     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2006.06.076     Document Type: Article

References (39)

1. Pringle C.R. Virus taxonomy-San Diego 1998. Arch Virol 143 7 (1998) 1449-1459
2. Juhasz K., and Easton A.J. Extensive sequence variation in the attachment (G) protein gene of avian metapneumovirus: evidence for two distinct subgroups. J Gen Virol 75 (1994) 2873-2880
3. Bayon-Auboyer M.-H., Arnauld C., Toquin D., and Eterradossi N. Nucleotide sequence of the F, L and G protein genes of two non-A/non-B avian metapneumoviruses (AMPV) reveal a novel AMPV subgroup. J Gen Virol 81 (2000) 2723-2733
4. Seal B.S. Avian Pneumovirus and emergence of a new type in the United States of America. Anim Health Res Rev 1 1 (2000) 67-72
5. Buys S.B., and De Preez J.H. A preliminary report on the isolation of a virus causing sinusitis in turkeys in South Africa and attempt to attenuate the virus. Turkeys 28 (1980) 36
6. Wilding G.P., Baxter-Jones C., and Grant M. Ciliostatic agent found rhinotracheitis. Vet Rec 118 (1986) 735
7. Wyeth P.J., Gough R.E., Chettle N., and Eddy R. Preliminary observations on a virus associated with turkey rhinotracheitis. Vet Rec 119 (1986) 139
8. Ling R., and Pringle C.R. Turkey rhinotracheitis virus: in vivo and in vitro polypeptide synthesis. J Gen Virol 69 (1988) 917-923
9. Cavangh D., and Barrett T. Pneumovirus-like characteristics of the mRNA and proteins of turkey rhinotracheitis virus. Virus Res 11 (1988) 241-256
10. Collins M.S., and Gough R.E. Characterization of a virus associated with turkey rhinotracheitis. J Gen Virol 69 (1988) 909-916
11. Senne D.A., Edson R.K., Pedersen J.C., and Panigrahy B. Avian pneumovirus update. Proceedings of 134th annual congress of American veterinary medical association. Reno, Nevada, USA, 1997 (1997), American Veterinary Medical Association, Schaumburg, IL 190
12. Cook J.K.A., Ellis M.M., Dolby C.A., Holmes H.C., Finney P.M., and Huggins M.B. A live attenuated turkey Rhinotracheitis Virus Vaccine. 1. Stability of the attenuated strain. Avian Pathol 18 (1989) 511-522
13. Cook J.K.A., Holmes H.C., Finney P.M., Ellis M.M., Huggins M.B., and Dolby C.A. A live attenuated turkey Rhinotracheitis Virus Vaccine. 2. The use of the attenuated strains as an experimental vaccine. Avian Pathol 18 (1989) 523-534
14. Williams R.A., Savage C.E., and Jones R.C. Development of a live attenuated vaccine against turkey rhinotracheitis. Avian Pathol 20 (1991) 45-55
15. Williams R.A., Savage C.E., Worthington K.J., and Jones R.C. Further studies on the development of a live attenuated vaccine against turkey rhinotracheitis. Avian Pathol 20 (1991) 585-596
16. Giraud P., Guittet M., Toquin D., and Bennejean G. Rhinotracheité infectieuse de la dinde (RTI). Progrés récents dans l'étiologie et la prevention. L'Aviculteur 477 (1987) 47-53
17. Pattison M. TRT in the field: field situation and control. In: Clark S.R., and Ginsburg L.M. (Eds). Proceedings & Technical Supplements of the Roche Avian Pneumovirus Workshop. St. Cloud, Minnesota, USA, 30 June-1 July 1998 (1998), Roche Vitamins Inc., Parsippanny, NJ RCD 9713 43-49
18. Banet-Noach C., Simanov L., and Perk S. Characterization of Israeli avian metapneumovirus strains in turkeys and chickens. Avian Pathol 34 3 (2005) 220-226
19. Naylor C., Shaw K., Britton P., and Cavanagh D. Appearance of type B avian pneumovirus in Great Britain. Avian Pathol 26 (1997) 327-338
20. Van de Zande S., Nauwynck H., Naylor C.J., and Pensaert M. Duration of cross-protection between subtypes A and B avian pneumovirus in turkeys. Vet Rec 147 (2000) 132-134
21. Cook J.K.A., Ellis M.M., and Huggins M.B. The pathogenesis of turkey rhinotracheitis virus in turkey poults inoculated with the virus alone or together with two strains of bacteria. Avian Pathol 20 (1991) 155-166
22. Naylor C.J., Al-Ankari A.R., Al-Afaleq A.I., Bradbury J.M., and Jones R.C. Exacerbation of Mycoplasma gallisepticum infection in turkeys by rhinotracheitis virus. Avian Pathol 21 (1992) 295-305
23. Van de Zande S., Nauwynck H., and Pensaert M. The clinical, pathological and microbiological outcome of an Escherichia coli O2:K1 infection in avian pneumovirus infected turkeys. Vet Microbiol 81 (2001) 353-365
24. Naylor C.J., and Jones R.C. Demonstration of a virulent subpopulation in a prototype live attenuated turkey rhinotracheitis vaccine. Vaccine 12 13 (1994) 1225-1230
25. Cavanagh D., Mawditt K., Britton P., and Naylor C.J. Longitudinal field studies of infectius bronchitis virus and avian pneumovirus in broiler using type-specific polymerase chain reactions. Avian Pathol 28 (1999) 593-605
26. Naylor C.J., Brown P.A., Edworthy N., Ling R., Jones R.C., Savage C.E., et al. Development of a reverse-genetics system for Avian pneumovirus demonstrates that the small hydrophobic (SH) and attachment (G) genes are not essential for virus viability. J Gen Virol 85 (2004) 3219-3227
27. Cook J.K.A., Darbyshire J.H., and Peters R.W. The use of chicken tracheal organ cultures for the isolation and assay of avian infectious bronchitis virus. Arch Virol 50 (1976) 109-118
28. Aldous E.W., and Alexander D.J. Detection and differentiation of Newcastle Disease virus (avian paramyxoviruses type 1). Avian Pathol 30 (2001) 117-128
29. Foni E., Chiapponi C., Lori D., De Marco M.A., Delogu M., Raffini E., et al. Detection of influenza A virus by RT-PCR and standard methods in experimental infection of Ducks. New Microbiol 28 1 (2005) 31-35
30. Naylor CJ. Studies on avian pneumovirus including development of a vaccine [PhD Thesis]. Liverpool (UK): Liverpool Univ.; 1993.
31. Ganapathy K., Cargill P.W., Montiel E., and Jones R.C. Interaction between live avian Pneumovirus and Newcastle Disease virus vaccines in SPF chickens. Avian Pathol 34 4 (2005) 297-302
32. Reed L.J., and Muench H. A simple method of estimating fifty percent end points. Am J Hyg 27 (1938) 493-497
33. Qingzhong Y., Barrett T., Brown T.D.K., Cook J.K.A., Green P., Skinner M.A., et al. Protection against turkey rhinotracheitis pneumovirus (TRTV) induced by a fowlpox virus recombinant expressing the TRTV fusion glycoprotein (F). Vaccine 12 (1994) 569-573
34. Kapczynski D.R. Development of a virosome vaccine against avian metapneumovirus subtype C for protection in turkeys. Avian Dis 48 2 (2004) 332-343
35. Kapczynski D.R., and Sellers H.S. Immunization of turkeys with a DNA vaccine expressing either the F or N gene of avian metapneumovirus. Avian Dis 47 4 (2003) 1376-1383
36. Naylor C.J., Cavanagh D., and Jones R.C. Live TRT vaccination in the UK: past present and future. In: Hafez H.M. (Ed). Proceedings of the 4th International symposium on turkey diseases. Berlin, Germany, 15-18 May 2002 (2002), DVG-Service-GmbH, Giessen 151-153
37. Bukreyev A., Whitehead S.S., Murphy B.R., and Collins P.L. Recombinant respiratory syncytial virus from which the entire SH gene has been deleted grows efficiently in cell culture and exhibits site-specific attenuation in the respiratory tract of the mouse. J Virol 71 (1997) 8973-8982
38. Karron R.A., Buonagurio D.A., Georgiu A.F., Whitehead S.S., Adamus J.E., Clements-Mann M.L., et al. Respiratory syncytial virus (RSV) SH and G proteins are not essential for viral replication in vitro: clinical evaluation and molecular characterization of a cold-passaged, attenuated RSV subgroup B mutant. Proc Natl Acad Sci USA 94 (1997) 13961-13966
39. Whitehead S.S., Bukreyev A., Teng M.N., Firestone C.-Y., St Claire M., Elkins W.R., et al. Recombinant respiratory syncytial virus bearing a deletion of either the NS2 or SH gene is attenuated in chimpanzees. J Virol 73 (1999) 3438-3442